GlaxoSmithKline Provides Information about Alli Recall

| Mar-27-14

GlaxoSmithKline (GSK) Consumer Healthcare is voluntarily recalling all alli weight loss products from U.S. and Puerto Rico retailers as the company believes that some packages of the product were tampered with and may contain product that is not authentic alli. GSK is conducting an investigation and is working with the knowledge of the U.S. Food and Drug Administration (FDA) on this retailer level recall.

GSK has provided a “consumer alert” document and a press release that provide additional information.

Similar Topics:

2017-06-27T14:05:34+00:00 Mar-27-14|Categories: Article|Tags: |